antibody_production_3

CROs speed up drug development. Biointron demonstrates how its expertise in antibody discovery, expression, and characterization helps partners achieve faster results.

Biointron's SVP of R&D, Lei Shi, PhD, discussed the processes of accelerating early discovery through HTP and high-speed antibody production during the Antibody Engineering & Therapeutics US 2023 conference in San Diego. Below is a summary of the talk.

Plasma cells secrete vast amounts of antibodies. Biointron describes their differentiation from B cells and the importance of this process in immune defense.

Antigen recognition initiates immune defense. Biointron explains how B cell activation shapes antibody production and drives effective immune responses.

Antibodies defend against disease and power modern biotech. Biointron shares ten fascinating facts that highlight their versatility and impact in research and therapy.

Recombinant antibody production ensures reproducibility and accuracy. Biointron provides reliable expression and purification to create research tools that advance discovery.

CHO cell line development is central to therapeutic antibody production. Biointron optimizes expression systems to deliver scalable, reliable, and high-yield solutions.

Therapeutic antibody discovery begins with screening. Biointron applies ELISA, SPR, and AI-driven tools to identify high-affinity antibodies with precision and speed.

Single-chain variable fragments (scFvs) combine small size with strong binding. Biointron highlights their history, uses in diagnostics and therapy, and production expertise.

Biointron streamlines antibody production and purification, applying recombinant expression, hybridoma methods, and chromatography techniques to ensure purity and performance.

From hybridoma to recombinant platforms, Biointron leads innovations in antibody production and engineering, enabling faster, more flexible, and reliable research solutions.

Biointron’s ISO 9001:2015-certified manufacturing standards ensure reliable, high-quality antibody production with rigorous QC processes and global CRO expertise.

Antibody fragmentation expands versatility. See how Fab, F(ab’)2, and scFv fragments are generated and applied in imaging, therapeutics, and diagnostics.

Speed drives better decisions. Discover how high-throughput recombinant antibody production shortens design-test cycles and accelerates research pipelines worldwide.

Explore ethical questions around antibody production in animals, the 3Rs principle, and how recombinant technology reduces animal use while ensuring high-quality science.